Skip to main content
Veterinary Medicines

TYLMASIN 250 mg/g premix for medicated feeding stuff

Authorised
  • Tylosin phosphate

Product identification

Medicine name:
TYLMASIN 250 mg/g premix for medicated feeding stuff
TYLMASIN 250 MG/G PREMISCELA PER ALIMENTI MEDICAMENTOSI
Active substance:
  • Tylosin phosphate
Target species:
  • Pig
  • Chicken
Route of administration:
  • In-feed use

Product details

Active substance and strength:
  • Tylosin phosphate
    250000.00
    international unit(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Premix for medicated feeding stuff
Withdrawal period by route of administration:
  • In-feed use
    • Pig
      • Meat and offal
        0
        day
    • Chicken
      • Meat and offal
        0
        day
      • Eggs
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FA90
Authorisation status:
  • Valid
Authorised in:
  • Italy
Available in:
  • Italy
Package description:
  • bag of 20 kg
  • bag of 5 kg
  • sachet of 1 kg

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • HuVepharma
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biovet AD
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 104818
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0225/001
Concerned member states:
  • Italy
  • Portugal

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 3/06/2022

Summary of Product Characteristics

English (PDF)
Published on: 11/04/2023
Download

Package Leaflet

English (PDF)
Published on: 11/04/2023
Download

Labelling

English (PDF)
Published on: 11/04/2023
Download

eu-PUAR-tylmasin-250-mg-g-premix-for-medicated-feeding-stuff-en.pdf

English (PDF)
Published on: 11/04/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."